JP Morgan maintains EverQuote at Overweight, raises price target to $30 from $29

What happened

JP Morgan maintained EverQuote at Overweight and raised its price target to $30 from $29, a 3.4% increase. The new target implies 23.6% upside from the Nov 2 close of $24.27.

Confirmed

Global impact / market context

A higher target from a major bank signals a more positive view on EverQuote, which means investors may expect the stock to rise toward $30. That can draw more buyers, supporting the share price and lowering the cost of raising capital.

Analyst inference

Other analysts recently set targets of $32 to $35, so JP Morgan's $30 sits below the group. This suggests some analysts see more upside, while all remain positive on the stock.

Analyst inference

What to watch

1. JP Morgan's $30 target is below the $32 to $35 range from B. Riley, Needham and Canaccord, all with Buy ratings, published over the past 30 days. Confirmed
2. Watch whether EverQuote's stock moves toward $30, since that would show investors accept JP Morgan's more positive view and could pull in buyers. Analyst inference
3. Watch for further analyst updates, because new targets above $30 could reinforce the positive view and below it could weaken the case. Analyst inference

Evidence

• Original source link unavailable